highly significantp < 0.01
Similarly, the longevity of tetracycline‐treated females (9.84 ± 2.86 days) was markedly reduced relative to control females (12.03 ± 2.61 days), with the difference being highly significant ( p < 0.01; Figure 9d ). 3.8.
Similarly, the longevity of tetracycline‐treated females (9.84 ± 2.86 days) was markedly reduced relative to control females (12.03 ± 2.61 days), with the difference being highly significant ( p < 0.01; Figure 9d ). 3.8.